IL1RL1 gene variations are associated with asthma exacerbations in children and adolescents using inhaled corticosteroids
Open Access
Abstract
No abstract availableKeywords
Funding Information
- American Asthma Foundation
- Instituto de Salud Carlos III (AC15/00015, FI16/00136, PI14/00844)
- National Institute on Minority Health and Health Disparities (1P60MD006902, 1R01MD010443, U54MD009523)
- GlaxoSmithKline foundation
- ZonMw (113201006)
This publication has 12 references indexed in Scilit:
- Rationale and Design of the Multiethnic Pharmacogenomics in Childhood Asthma ConsortiumPharmacogenomics, 2017
- No evidence of large genetic effects on steroid response in asthma patientsJournal of Allergy and Clinical Immunology, 2017
- Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasivenessScientific Reports, 2017
- Pharmacogenetics of asthmaCurrent Opinion in Pulmonary Medicine, 2017
- IL1RL1 asthma risk variants regulate airway type 2 inflammationJCI Insight, 2016
- The role of the IL-33/IL-1RL1 axis in mast cell and basophil activation in allergic disordersMolecular Immunology, 2015
- Eosinophils in the Spotlight: Eosinophilic airway inflammation in nonallergic asthmaNature Medicine, 2013
- Decoding asthma: Translating genetic variation in IL33 and IL1RL1 into disease pathophysiologyJournal of Allergy and Clinical Immunology, 2013
- T-helper Type 2–driven Inflammation Defines Major Subphenotypes of AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarctionNature Genetics, 2009